NantHealth

NantHealth, a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.

Company Growth (employees)
Type
Public
HQ
Culver City, US
Founded
2007
Size (employees)
498 (est)+5%
NantHealth was founded in 2007 and is headquartered in Culver City, US

Key People at NantHealth

Patrick Soon-Shiong

Patrick Soon-Shiong

Founder

NantHealth Office Locations

NantHealth has offices in Culver City and London
Culver City, US (HQ)
9920 Jefferson Blvd
London, GB
Warnford Court, 29 Throgmorten Street

NantHealth Data and Metrics

NantHealth Financial Metrics

NantHealth's revenue was reported to be $22.5 m in Q1, 2017
USD

Revenue (Q1, 2017)

22.5 m

Gross profit (Q1, 2017)

3.5 m

Gross profit margin (Q1, 2017), %

15%

Net income (Q1, 2017)

(41.1 m)

EBIT (Q1, 2017)

(32.6 m)

Market capitalization (17-Aug-2017)

342.6 m

Cash (31-Mar-2017)

124.9 m
NantHealth's current market capitalization is $342.6 m.
USDQ1, 2017

Revenue

22.5 m

Cost of goods sold

19 m

Gross profit

3.5 m

Gross profit Margin, %

15%

R&D expense

13.4 m

General and administrative expense

20.9 m

Operating expense total

34.3 m

EBIT

(32.6 m)

EBIT margin, %

(145%)

Interest expense

(4 m)

Pre tax profit

(40.8 m)

Income tax expense

282 k

Net Income

(41.1 m)
USDFY, 2016

Accounts Payable

39.4 m
USDQ1, 2017

Cash

124.9 m

Accounts Receivable

8.9 m

Inventories

2.2 m

Current Assets

146.1 m

PP&E

33.1 m

Goodwill

131.1 m

Total Assets

639.5 m

Accounts Payable

3.7 m

Current Liabilities

51 m

Additional Paid-in Capital

885.4 m

Retained Earnings

(516.4 m)

Total Equity

369.5 m

Financial Leverage

1.7 x
USDFY, 2016
USDQ1, 2017

Net Income

(41.1 m)

Accounts Receivable

8.9 m

Inventories

2.2 m

Accounts Payable

3.7 m
Y, 2017

Financial Leverage

1.7 x

NantHealth Market Value History

Traffic Overview of NantHealth

NantHealth Online and Social Media Presence

NantHealth Company Life and Culture

You may also be interested in